Journals / Türk Oftalmoloji Dergisi / 2013 / Cilt: 43 - Sayı: 3

Management of encapsulated blebs after filtering surgery

Filtran cerrahi sonrası gelişen enkapsüle bleblere yaklaşım

Pages
173–177
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The IOPs before and postoperative 1. week, 1., 3., and 6.months were respectively 26,5±8,6 mmHg, 11,9±2,6 (5-18) mmHg, 14,5±3,8 (11-20) mmHg, 15,2±5,6 (8-20) mmHg ve 14,8±1,4 (8-28) mmHg (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the results of the bleb needling of encapsulated blebs with 1% Mitomycine-C, after trabeculectomy surgery Material and Methods: 98 eyes of 90 glaucoma patients who underwent trabeculectomy were evaluated retrospectively between July 2009-September 2011.
📊
Key Findings & Data:Twenty-five eyes of 24 patients who developed encapsulated bleb with at least 3 months follows enrolled the study.
💡
Conclusion & Impact:The IOPs before and postoperative 1. week, 1., 3., and 6.months were respectively 26,5±8,6 mmHg, 11,9±2,6 (5-18) mmHg, 14,5±3,8 (11-20) mmHg, 15,2±5,6 (8-20) mmHg ve 14,8±1,4 (8-28) mmHg (p
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the results of the bleb needling of encapsulated blebs with 1% Mitomycine-C, after trabeculectomy surgery Material and Methods: 98 eyes of 90 glaucoma patients who underwent trabeculectomy were evaluated retrospectively between July 2009-September 2011. Twenty-five eyes of 24 patients who developed encapsulated bleb with at least 3 months follows enrolled the study. These patients had undergone bleb needling with 1% Mitomycine-C (16 eyes) since medications were not efficient for IOP control. The pre- and post-needling intraocular pressures (IOP) has compared with the ones who had controlled with antiglaucoma medications (9 eyes). Results: Encapsulated bleb was seen 25 (25,6%) eyes of 24 patients out of 98 eyes of 90 patients who had trabeculectomy.The mean age was 62,6±13,6 (23-83) years and the mean follow-up time was 5,7±4,4 (3-20) months. The mean time that encapsulated blebs were diagnosed 4,1±1,5 (2,5-8) weeks after the trabeculectomy. The number of the eyes who had controlled IOP just with medication was 9 (36%) eyes with 5,7±4,0 (3-14) months mean follow-up time. Mtm-C 1% bleb needling was performed to 16 eyes (64%) at mean 9.1±3.2 (3-15) weeks after trabeculectomy who haven’t had success with medical treatment. The IOPs before and postoperative 1. week, 1., 3., and 6.months were respectively 26,5±8,6 mmHg, 11,9±2,6 (5-18) mmHg, 14,5±3,8 (11-20) mmHg, 15,2±5,6 (8-20) mmHg ve 14,8±1,4 (8-28) mmHg (p

Özet

Amaç: Trabekülektomi cerrahisi sonrası gelişen enkapsüle bleb (EB)’lerde Mitomisin-C (MMC) uygulanarak yapılan bleb iğneleme tekniğinin sonuçlarının değerlendirilmesi. Gereç ve Yöntem: Temmuz 2009-Eylül 2011 tarihleri arasında trabekülektomi operasyonu uygulanmış olan 90 hastanın 98 gözü geriye dönük incelendi. En az 3 ay takibi olan ve EB geliştiği tespit edilen 24 hastanın 25 gözü çalışma kapsamına alındı. Medikal tedavi ile GİB kontrolü sağlanan (9 göz) ve medikal tedaviye rağmen göz içi basınç (GİB) kontrolü sağlanamayan %1’lik MMC ile iğneleme yapılan (16 göz) hastaların tedavi öncesi ve sonrası GİB değerleri karşılaştırıldı. Sonuçlar: Trabekülektomi sonrası değerlendirilen 90 hastanın 98 gözünden, 24 hastanın 25 (%25,6) gözünde enkapsüle bleb saptandı. Ortalama yaş 62,6±13,6 (23-83), ortalama takip süresi 5,7±4,4 (3-20) ay idi. Hastalarda EB varlığı, trabekülektomi sonrası ortalama 4,1±1,5 (2,5-8) haftada tespit edildi. Yalnız medikal tedavi ile GİB kontrol altına alınan hasta sayısı 9 (%36) ve ortalama takip süresi 5,7±4,0 (3-14) ay idi. Medikal tedavi ile başarı elde edilemeyen 16 (% 64) göze MMC’li bleb iğneleme, trabekülektomi sonrası ortalama 9.1±3.2 (3-15) haftada yapıldı. İğneleme öncesi ve sonrası 1. hafta, 1. ay, 3. ay ve 6. ay ortalama GİB’ları sırasıyla 26,5±8,6 mmHg, 11,9±2,6 (5-18) mmHg, 14,5±3,8 (11-20) mmHg, 15,2±5,6 (8-20) mmHg ve 14,8±1,4 (8-28) mmHg idi (p

🔖

Cite This Article

DEMİROK, A., ŞATANA, B., ALTAN, Ç., BOZKURT, E., BAZ, Ö., BAŞARIR, B., PAŞAOĞLU, I. (2022). Management of encapsulated blebs after filtering surgery. Türk Oftalmoloji Dergisi, Cilt: 43 - Sayı: 3, 173–177. https://ajindex.com/articles/638164

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Pederson JE, Smith SG. Surgical management of encapsulated filtering blebs. Ophthalmology. 1985;92:955-8.
  2. Liebmann JM, Ritch R. Glaucoma Therapy. In: Ritch R, Shields MB, Krupin T, eds. Complications of glaucoma filtering surgery, Chapter 84, Glaucoma Surgery, Part 7, Volume 3, The Glaucomas, (2th ed). St. Louis; Mosby-Year Book Inc; 1996;1703-36.
  3. Ewing RH, Stamper RL. Needle revision with and without 5-fluorouracil for the treatment of failed filtering blebs. Am J Ophthalmol. 1990;110:254-9.
  4. Mietz H, Jacobi PC, Welsandt G, Krieglstein GK. Trabeculectomies in fellow eyes have an increased risk of Tenon’s capsule cysts. Ophthalmology. 2002;109:992-7.
  5. Cheung JC, Wright MM, Murali S, Pederson JE. Intermediate-term outcome of variable dose mitomycin-C filtering surgery. Ophthalmology. 1997;104:143-9.
  6. Yalvac IS, Yuzer H, Akgun U, Kasım R, Duman S. İlerleyen zaman içinde trabekülektominin etkinliği. Tjo. 1998;28:318-21.
  7. Feldman RM, Gross RL, Spaeth GL, et al. Risk factors for the development of Tenon's capsule cysts after trabeculectomy. Ophthalmology. 1989;96:336-41.
  8. Sherwood MB, Spaeth GL, Simmons ST, et al. Cysts of Tenon's capsule following filtration surgery, Medical management. Arch Ophthalmol. 1987;105:1517-21.
  9. Meyer JH, Guhlmann M, Funk J. How successful is the filtering bleb "needling"?. Klin Monbl Augenheilkd. 1997;210:192-6.
  10. Shetty RK, Wartluft L, Moster MR. Slit-lamp needle revision of failed filtering blebs using high-dose mitomycin C. J Glaucoma. 2005;14:52-6.
  11. Skuta GL, Parrish RK 2nd. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32:149-70.
  12. Loftfield K, Ball SF. Filtering bleb encapsulation increased by steroid injection. Ophthalmic Surg. 1990;21:282-7.
  13. Ophir A, Ticho U. A randomized study of trabeculectomy and subconjunctival administration of fluorouracil in primary glaucomas. Arch Ophthalmol. 1992;110:1072-5.
  14. Ruderman JM, Welch DB, Smith MF, Shoch DE. A randomized study of 5- fluorouracil and filtration surgery. Am J Ophthalmol. 1987;104:218-24.
  15. Altan Ç, Şatana B, Baz Ö, et al. Trabekülektomi sonrası enkapsüle bleb gelişimi ile ilişkili faktörler. Glo-Kat. 2012;2:95-100.
  16. Richter CU, Shingleton BJ, Bellows AR, Hutchinson BT, O'Connor T, Brill I. The development of encapsulated filtering blebs. Ophthalmology. 1988;95:1163-8.
  17. Scott DR, Quigley HA. Medical management of a high bleb phase after trabeculectomies. Ophthalmology. 1988;95:1169-73.
  18. Costa VP Correa MM, Kara-Jose N. Needling versus medical treatment in encapsulated ble